On Wednesday, UBS reaffirmed its Buy rating on Texas Instruments (NASDAQ:) stock, maintaining the price target of $250.00.
The firm’s positive stance follows Texas Instruments’ capital management discussion, which highlighted the company’s flexibility in capital expenditures for 2026 and beyond.
The analyst praised Texas Instruments’ strategy, particularly its potential to regain pre-COVID market share in the analog segment, which could significantly boost growth.
Texas Instruments’ recent capital management call provided insights that could shift investor sentiment favorably. Notably, the company’s ability to recapture market share in the analog sector was emphasized.
According to UBS, every 1% of market share regained could add approximately 5-6 percentage points of unique growth from the current low point. This recovery is seen as a counter to the prevailing skepticism among investors, particularly concerning competition from Chinese firms.
UBS also highlighted Texas Instruments’ competitive edge in the Chinese market, attributing it to a cost position that is expected to improve further under the company’s current plan.
The analyst notes that Texas Instruments is uniquely positioned to compete effectively in China, which could play a crucial role in the company’s future growth.
In terms of financial valuation, UBS pointed out that Texas Instruments’ free cash flow (FCF) per share could reach approximately $10 in a mid-point revenue scenario, which is more optimistic than both UBS’s model and the consensus estimate of less than $7 per share.
Additionally, new commentary regarding “maintenance” capital expenditures suggests that the company could increase FCF to around $14 per share in a more favorable scenario, particularly if 2026 is seen as a peak year with limited growth thereafter.
In conclusion, while UBS has slightly increased its estimates for Texas Instruments’ earnings per share (EPS) and FCF per share for 2025 and 2026, the price target remains unchanged at $250. The firm’s analysis indicates confidence in Texas Instruments’ strategic direction and financial prospects.
In other recent news, Texas Instruments has made significant strides in its financial trajectory and strategic investments. The semiconductor company has reduced its 2026 capital expenditure forecast and is expecting an improvement in gross margins, according to Citi, which upgraded the company’s stock rating from Neutral to Buy. Meanwhile, Stifel maintained a Hold rating, acknowledging a shift in the company’s strategy towards a greater reliance on sales performance.
Texas Instruments also announced a substantial increase in its projected free cash flow per share by 2026, with estimates ranging from $8 to $12, surpassing the analyst consensus estimate of $6.91.
Deutsche Bank adjusted its price target for Texas Instruments to $200.00, maintaining a Hold rating on the stock, while Bernstein SocGen Group maintained an Underperform rating, citing potential long-term capex cuts and structural concerns.
In addition to these financial developments, Texas Instruments has outlined plans to construct three new facilities and expand its 300mm production capacity, a move commended by Elliott Investment Management.
The company has secured up to $1.6 billion in funding from the U.S. CHIPS and Science Act for the construction of these new facilities. These recent developments underscore Texas Instruments’ strategic investments and financial performance.
InvestingPro Insights
As we consider the insights provided by UBS on Texas Instruments, it’s beneficial to look at the company through the lens of current InvestingPro data and tips. With a market capitalization of $184.93 billion and a P/E ratio standing at 34.9, Texas Instruments is a heavyweight in the semiconductor industry. Despite concerns about sales decline, the company’s gross profit margin remains strong at 59.36%, indicating efficient operations. Additionally, Texas Instruments has a notable dividend yield of 2.57%, which is supported by a history of raising its dividend for 20 consecutive years, showcasing a commitment to returning value to shareholders.
InvestingPro Tips further illuminate the company’s position. Texas Instruments is acknowledged for being a prominent player in the Semiconductors & Semiconductor Equipment industry, and with six analysts having revised their earnings upwards for the upcoming period, there appears to be a positive sentiment building around the company’s financial performance. However, it’s important to note that the company is trading at high valuation multiples, such as a P/E ratio and Price/Book, which suggests high investor expectations for future earnings. For those interested in a deeper dive into Texas Instruments’ financial health and market performance, InvestingPro offers additional tips that can be accessed through their platform.
The combination of UBS’s analysis and InvestingPro’s real-time data and tips provides a comprehensive view of Texas Instruments’ current market standing and potential for growth. With additional insights available on InvestingPro, investors can make well-informed decisions regarding their interest in TXN shares.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.